🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
This is a multicenter Phase 1b study evaluating the safety, tolerability, a...
Status
Completed
Location
City of Hope
Start Date
2021-07-29
Trial ID
NCT05075603
Treatments Being Tested
This is a randomized, open label, multicenter phase III trial comparing the...
Status
Completed
Location
Moores UC San Diego Cancer Center
Start Date
2019-05-09
Trial ID
NCT03570892
This was a Retrospective cohort study based on the PMSI data source...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-12-09
Trial ID
NCT05349201
This was a multi-center Phase II study investigating the efficacy and safet...
Status
Terminated
Location
Childrens Hospital Los Angeles Divisionof Hematology/Oncology
Start Date
2020-10-19
Trial ID
NCT04225676
Treatments Being Tested
To use a consistent and standardized platform to retrospectively and prospe...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-29
Trial ID
NCT05865301
Treatments Being Tested
This phase I clinical trial studies the side effects and best dose of CD19-...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-12-16
Trial ID
NCT02529813
Treatments Being Tested
This is a Phase 1b study of participants with Diffuse Large B Cell Lymphoma...
Status
Withdrawn
Location
Princess Margaret Cancer Centre
Start Date
2024-04-05
Trial ID
NCT06003179
Treatments Being Tested
This early phase I trial investigates how well duvelisib exposure before CA...
Status
Completed
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2022-01-13
Trial ID
NCT04890236
Treatments Being Tested
This trial aims to compare the benefits and risks of tisagenlecleucel to bl...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-06-05
Trial ID
NCT03628053
Treatments Being Tested